RxDoctor Payments Data

Kristine Bailey

Psychiatric/Mental Health · Lakewood, NYNPI 1669653952

Payments from drug & device makers

$1,277in general payments, 2019–2025

Across 67 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$332
  • Otsuka America Pharmaceutical, Inc.$278
  • Lundbeck LLC$151
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$78
  • Corium, LLC$73
  • Ironshore Pharmaceuticals Inc.$68
  • plus $296 from 8 others

What the payments were for

  • Food & beverage$1,23096%
  • Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,277 in reported general payments places this provider in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$21,311
Medicare patients
41
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl56$77,857
RexultiBrexpiprazole40$57,864
Lurasidone Hcl35$13,795
Chlorpromazine Hcl12$11,777
XanaxAlprazolam12$7,246
Aripiprazole97$2,479
Lisdexamfetamine Dimesylate16$2,324
Paroxetine CrParoxetine Hcl25$2,193
Bupropion XlBupropion Hcl82$2,092
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,885
Duloxetine Hcl98$1,798
Quetiapine Fumarate138$1,782
Fluvoxamine Maleate ErFluvoxamine Maleate12$1,587
Fluvoxamine Maleate26$1,514
Venlafaxine Hcl ErVenlafaxine Hcl136$1,498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$332$77,85756 claims
Otsuka America Pharmaceutical, Inc.Rexulti$278$57,86440 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Lakewood

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →